Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant beta-2 Microglobulin antibody (full length)

The Rabbit Monoclonal anti-beta-2 Microglobulin antibody (Clone B2M-1857R) (ABIN5707813) specifically detects beta-2 Microglobulin in WB, FACS, IF and IHC (p). The antibody is reactive with Human samples.
Catalog No. ABIN5707813
$640.46
Plus shipping costs $50.00
Shipping to: United States
Delivery in 2 to 4 Business Days

Quick Overview for Recombinant beta-2 Microglobulin antibody (full length) (ABIN5707813)

Target

See all beta-2 Microglobulin (B2M) Antibodies
beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

Antibody Type

Recombinant Antibody

Reactivity

  • 275
  • 64
  • 51
  • 44
  • 11
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 163
  • 148
  • 9
  • 6
  • 2
  • 2
  • 2
Rabbit

Clonality

  • 198
  • 133
  • 1
Monoclonal

Conjugate

  • 163
  • 35
  • 24
  • 14
  • 13
  • 7
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This beta-2 Microglobulin antibody is un-conjugated

Application

  • 192
  • 143
  • 121
  • 95
  • 84
  • 54
  • 51
  • 47
  • 26
  • 21
  • 17
  • 15
  • 14
  • 13
  • 9
  • 6
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone

B2M-1857R
  • Binding Specificity

    • 22
    • 22
    • 15
    • 8
    • 6
    • 6
    • 5
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    full length

    Purpose

    Recombinant B2M Antibody / Beta-2 Microglobulin

    Purification

    Protein A affinity chromatography

    Immunogen

    Full length recombinant human protein was used as the immunogen for the recombinant B2M antibody.

    Isotype

    IgG, kappa
  • Application Notes

    Optimal dilution of the recombinant B2M antibody should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.2 mg/mL

    Buffer

    0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store the recombinant B2M antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
  • Target

    beta-2 Microglobulin (B2M) (beta-2-Microglobulin (B2M))

    Alternative Name

    B2M

    Background

    Recognizes a protein of 12 kDa, identified as beta-2 microglobulin. Major histocompatibility complex (MHC) class 1 Molecules bind to antigens for presentation on the surface of cells. The proteasome is responsible for producing these antigens from the components of foreign pathogens. MHC class 1 Molecules consist of an alpha heavy chain that contains three subdomains (alpha1, alpha2, alpha3) and a non-covalent associating light chain, known as beta-2-Microglobulin. Beta-2-Microglobulin associates with the alpha3 subdomain of the alpha heavy chain and forms an immunoglobulin domain-like structure that mediates proper folding and expression of MHC class 1 Molecules. The alpha1 and alpha2 domains of the alpha heavy chain form the peptide antigen-binding cleft. Mutations in the beta-2-Microglobulin gene can enhance the progression of malignant melanoma phenotypes.

    UniProt

    P61769

    Pathways

    TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Blank Blank Blank Blank
Blank Blank Blank Blank
Chat with us!